Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transjugular liver biopsy. An update.

Diego García-Compean1, Carlos Cortés

  • 1Servicio de Gastroenterología Hospital Universitario Dr. José E González, Universidad Autónoma de Nuevo León Monterrey N.L., C.P. 64460, México. digarcia@ccr.dsi.uanl.mx

Annals of Hepatology
|October 27, 2004
PubMed
Summary

Transjugular liver biopsy offers a safe and effective method for diagnosing liver diseases, especially when percutaneous biopsy is not an option. This minimally invasive procedure yields high diagnostic accuracy and leads to treatment changes in a majority of patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[AMP Says Thank You!]

Acta medica portuguesa·2026
Same author

Clinical and Prognostic Implications of Precipitating Factors in Patients With Spontaneous Coronary Artery Dissection.

The American journal of cardiology·2025
Same author

Murray law-based angiography-derived assessment of coronary microcirculatory resistance in myocardial ischemia and non-obstructive coronary arteries.

International journal of cardiology·2025
Same author

[Medicine for Peace: An Ethical and Professional Imperative].

Acta medica portuguesa·2025
Same author

ESP-INOCA: Rationale and design of a national multicentre registry for prognostic stratification in patients with suspected myocardial ischaemia and non-obstructive coronary arteries.

International journal of cardiology·2025
Same author

[Medicine for Peace: An Ethical and Professional Imperative].

Acta medica portuguesa·2025

Area of Science:

  • Hepatology
  • Interventional Radiology
  • Diagnostic Procedures

Background:

  • Transjugular liver biopsy, first reported in 1967, has evolved significantly.
  • Technological advancements in needles have improved tissue sample quality.
  • Its indications have expanded, offering an alternative to percutaneous biopsy.

Purpose of the Study:

  • To evaluate the efficacy and safety of transjugular liver biopsy.
  • To highlight its role in diagnosing hepatic diseases, particularly in contraindicated cases.
  • To assess the impact of diagnostic yield on patient treatment.

Main Methods:

  • Review of transjugular liver biopsy technique and its historical development.
  • Analysis of indications, contraindications, and patient benefits.

Related Experiment Videos

  • Assessment of complication rates, including minor and major adverse events.
  • Evaluation of diagnostic accuracy and treatment modification rates.

    • Main Results:

    • Transjugular liver biopsy is indicated in patients with contraindications to percutaneous biopsy.
    • The procedure demonstrates a high success rate with low complication rates (1-15% minor, 1-3% major).
    • Procedure-related mortality is low (0.2-0.3%).
    • Diagnosis from transjugular biopsy led to treatment changes in 50% (acute), 62% (chronic), and 87% (transplant) of patients.

    Conclusions:

    • Transjugular liver biopsy is a valuable diagnostic tool for hepatic diseases.
    • It is a safe and well-tolerated procedure with rare complications and low mortality.
    • The diagnostic information obtained frequently guides therapeutic decisions.